Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Dec;51(12):4161-6.
doi: 10.1128/JCM.01743-13. Epub 2013 Oct 9.

Exploring alternative biomaterials for diagnosis of pulmonary tuberculosis in HIV-negative patients by use of the GeneXpert MTB/RIF assay

Affiliations
Comparative Study

Exploring alternative biomaterials for diagnosis of pulmonary tuberculosis in HIV-negative patients by use of the GeneXpert MTB/RIF assay

Shubhada Shenai et al. J Clin Microbiol. 2013 Dec.

Abstract

The utility of the GeneXpert MTB/RIF (Xpert) assay for detection of Mycobacterium tuberculosis in sputum samples has been extensively studied. However, the performance of the Xpert assay as applied to other readily accessible body fluids such as exhaled breath condensate (EBC), saliva, urine, and blood has not been established. We used the Xpert assay to test EBC, saliva, urine, and blood samples from HIV-negative, smear- and culture-positive pulmonary tuberculosis (TB) patients for the presence of M. tuberculosis. To compare the ability of the assay to perform bacterial load measurements on sputum samples with versus without sample processing, the assay was also performed on paired direct and processed sputum samples from each patient. The Xpert assay detected M. tuberculosis in none of the 26 EBC samples (sensitivity, 0.0%; 95% confidence interval [95% CI], 0.0%, 12.9%), 10 of the 26 saliva samples (sensitivity, 38.5%; 95% CI, 22.4%, 57.5%), 1 of 26 urine samples (sensitivity, 3.8%; 95% CI, 0.7%, 18.9%), and 2 of 24 blood samples (sensitivity, 8.3%; 95% CI, 2.3%, 25.8%). For bacterial load measurements in the different types of sputum samples, the cycle thresholds of the two M. tuberculosis-positive sputum types were well correlated (Spearman correlation of 0.834). This study demonstrates that the Xpert assay should not be routinely used to detect M. tuberculosis in EBC, saliva, urine, or blood samples from HIV-negative patients suspected of having pulmonary tuberculosis. As a test of bacterial load, the assay produced similar results when used to test direct versus processed sputum samples. Sputum remains the optimal sample type for diagnosing pulmonary tuberculosis in HIV-negative patients with the Xpert assay.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Detection of TB in different body fluids collected from culture-proven pulmonary TB cases. The Xpert assay was used to test each body fluid, EBC, saliva, urine, and blood, for TB. The assay cycle threshold (CT) (Ct in the figure) values for each body fluid are compared to the CT value of the direct sputum sample collected from the same patient on the same day. Samples where TB was not detected have been plotted at a CT value of 40, which is above the highest CT value used to identify TB in the Xpert assay.
Fig 2
Fig 2
Correlation between direct and processed sputum specimens collected from confirmed pulmonary TB cases at the baseline and during treatment. The Xpert assay was performed on paired samples. The cycle threshold (CT) (Ct in the figure) value for each direct sputum sample is plotted in comparison to the CT value of the processed sputum sample obtained from the same patient on the same day. Samples where TB was not detected have been plotted at a CT value of 40, which is above the highest observed CT value.

References

    1. Wolf H, Mendez M, Gilman RH, Sheen P, Soto G, Velarde AK, Zimic M, Escombe AR, Montenegro S, Oberhelman RA, Evans CA. 2008. Diagnosis of pediatric pulmonary tuberculosis by stool PCR. Am. J. Trop. Med. Hyg. 79:893–898 - PMC - PubMed
    1. Horvath I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJ, Corradi M, Dekhuijzen R, Dweik RA, Dwyer T, Effros R, Erzurum S, Gaston B, Gessner C, Greening A, Ho LP, Hohlfeld J, Jobsis Q, Laskowski D, Loukides S, Marlin D, Montuschi P, Olin AC, Redington AE, Reinhold P, van Rensen EL, Rubinstein I, Silkoff P, Toren K, Vass G, Vogelberg C, Wirtz H, ATS/ERS Task Force on Exhaled Breath Condensate 2005. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur. Respir. J. 26:523–548 - PubMed
    1. Montuschi P. 2007. Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther. Adv. Respir. Dis. 1:5–23 - PubMed
    1. Schreiber J, Meyer C, Rusch-Gerdes S, Richter E, Beck H, Fischer JF, Rosahl W. 2002. Mycobacterium tuberculosis gene-amplification in breath condensate of patients with lung tuberculosis. Eur. J. Med. Res. 7:290–291 - PubMed
    1. Chiappin S, Antonelli G, Gatti R, De Palo EF. 2007. Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clin. Chim. Acta 383:30–40 - PubMed

Publication types

MeSH terms